海南将开放创新发展中医药服务贸易 建中医药现代产业体系

2020-11-06 王子谦 中国新闻网

为全面推动中医药在海南自由贸易港传承创新发展,中共海南省委、海南省人民政府4日对外公布《关于促进中医药在海南自由贸易港传承创新发展的实施意见》,明确将开放创新发展中医药服务贸易,争取中医药事业在海南自

为全面推动中医药在海南自由贸易港传承创新发展,中共海南省委、海南省人民政府4日对外公布《关于促进中医药在海南自由贸易港传承创新发展的实施意见》,明确将开放创新发展中医药服务贸易,争取中医药事业在海南自贸港建设中实现早期收获。

意见明确,海南将充分利用自贸港政策制度优势,将中医药服务贸易作为全省开展服务贸易创新发展的重点领域进行突破。将中医药服务纳入海南自贸港新增鼓励类产业目录,吸引更多中医药服务贸易企业落户。重点支持三亚市中医院建设国家中医药服务出口基地。

意见指出,海南将融合创新发展中医药健康旅游。围绕国际旅游消费中心建设任务,将中医药生态、绿色和健康的理念与旅游深度融合,打造海南省独特的中医药健康旅游新业态新模式。鼓励省内公立医院拓展服务项目,增设与休闲度假功能相结合的康养中心。鼓励旅行社与各类中医医疗、康养机构合作,将中医药与观光、休闲、度假类产品结合,在国内外市场推广。

海南将对标自贸港建设需要,构建高水平中医药服务体系,到2022年实现县办中医医疗机构全覆盖,实现所有社区卫生服务机构、乡镇卫生院和70%以上的村卫生室具备中医药服务能力。

海南将发挥中医药在疾病预防、治疗、康复中的独特优势。允许非卫生技术人员进入医疗机构从事治未病服务。到2022年,每个县级中医院建设1个以上中医重点(特色)专科,全省所有三级中医院、50%以上二级中医院设置康复科,所有康复医院均能提供中医药服务。

在中药研究方面,海南将充分利用独特的热带气候资源,开展南药、芳香药、黎药、海洋药资源的研究、保护和开发利用工作。到2022年力争南药、黎药、中成药产值占全省医药工业总产值12%以上。此外,还将建立健全符合中医药特点和自贸港建设需求的中药注册管理制度。将中医药纳入海南省重大新药创制国家重大科技专项成果转移转化试点范围,鼓励以医疗机构制剂、经典名方和南药、黎药、海洋药等为基础研制中药新药。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-25 ms6000000582781674

    发展不错啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-18 血液小医生

    发展中医药

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-07 lilianxiang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-07 wgsun
  6. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-07 cathymary
  7. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 胭脂22

    发展中医药,民族特色

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 146465bem06暂无昵称

    开放创新发展中医药

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1968602, encodeId=ee20196860215, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Mar 14 04:25:58 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902019, encodeId=9c4190201947, content=发展不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/3ae3c9cb0a704d429012c09565762c77/a220da329ada44e18150b2f2dfae4bd4.jpg, createdBy=ae045431962, createdName=ms6000000582781674, createdTime=Wed Nov 25 04:11:27 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900219, encodeId=34c790021916, content=发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/zN0zNa6WxPrMcb0wXicHafjnuglnleugIQya9bOAOpIYA1e3iceY7HpfzVluEbUKuiaPYo9znTicRvALNvhO6kfI0Q/132, createdBy=2ae65317885, createdName=血液小医生, createdTime=Wed Nov 18 16:16:53 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285939, encodeId=4346128593916, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399030, encodeId=259b1399030e1, content=<a href='/topic/show?id=2160655623c' target=_blank style='color:#2F92EE;'>#海南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65562, encryptionId=2160655623c, topicName=海南)], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/A238DC699B2D7CD2658C9F8A5E577878/100, createdBy=92462182538, createdName=wgsun, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Nov 07 15:25:58 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897267, encodeId=24f989e267f2, content=发展中医药,民族特色, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae85432288, createdName=胭脂22, createdTime=Fri Nov 06 09:54:36 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897243, encodeId=a92889e243f0, content=开放创新发展中医药, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Fri Nov 06 07:05:41 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049780, encodeId=d06b1049e80f9, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Nov 06 03:25:58 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 运动yd

    中医中药,大多被人诋毁,不过梅斯里总是客观公正的

    0

相关资讯

世界流感日:专家谈中医药防治流感的价值

11月1日,2020世界流感大会暨世界流感日学术活动在北京召开。会上王辰院士、高福院士等专家,就流感大流行防控策略、中医药治疗流感的临床价值等内容进行了专题报告。

重磅文件出台,中医药要火了

重磅文件出台,中医药大发展来了。

张其成:发挥特色优势,推动中医药全程参与疾病救治

中医药参与抗击疫情,取得了令人瞩目的成效,是今年两会深受医药卫生界委员们关注的话题之一。作为中医药文化专家,全国政协委员、北京中医药大学国学院教授张其成围绕在常态化疫情防控下充分发挥中医药特色优势、推

广西提升中医药壮瑶医药服务能力 加快建设基层中医馆

7月17日,广西中医药管理局党组书记、局长姚春介绍广西促进中医药壮瑶医药传承创新发展有关情况。 黄艳梅 摄

OCC 2020:从新冠肺炎的中医救治谈中成药的合理应用

新冠肺炎疫情目前仍在全球蔓延,在这场战疫行动中,中医药成为中国救治方案的亮点。在第十四届东方心脏病学会议(OCC2020)上,吴宗贵教授报告了中医药在新冠肺炎救治中发挥的杰出作用及其带来的相关启示。

湖北打造“三大高地”促进中医药振兴发展

“中医药和中西医结合是这次疫情防控的一大特色和亮点。”湖北省卫健委一级巡视员姚云在湖北省新型冠状病毒肺炎疫情防控指挥部7日召开的新闻发布会上表示。